SSU72P6
associated omics dataQ-omics provides the consensus-scored SSU72P6 profile across patient tissues and cancer cell-line models. SSU72P6 expression is associated with patient survival in 2 of 34 cancer types, with the highest sampling consensus in LUAD.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for SSU72P6 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes SSU72P6 survival associations across molecular data types. SSU72P6 RNA expression shows survival associations in the most cancer types (2). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible SSU72P6 RNA expression–survival associations across cancer types. High SSU72P6 expression shows unfavorable associations in LUAD and STAD. The LUAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify LUAD as the clearest survival context for SSU72P6 RNA expression.
